A new bright-field dual-colour chromogenic and silver in situ hybridization method for the detection of FGFR1 gene copy number status

Virchows Archiv

Volumn 464, Issue 5, 2014, Pages 547-551

  Boehm, Diana ^a   Vogel, Wenzel ^a   Franzen, Alina ^a   Schrock, Andreas ^a,b   Bootz, Friedrich ^b   Heaseley, Lynn E ^c   Braun, Martin ^a   Perner, Sven ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Amplification; CISH; FGFR1; FISH; Head and neck squamous cancer; SISH

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ARTICLE; CENTROMERE; COHORT ANALYSIS; COMBINED CHROMOGENIC WITH SILVER IN SITU HYBRIDIZATION; COMPARATIVE STUDY; CORRELATION COEFFICIENT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; POLYPLOIDY; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; GENE DOSAGE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TISSUE ARRAY ANALYSIS;

EID: 84902318218     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1564-z     Document Type: Article

References (14)

1. Dutt, A et al (2011) Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS One 6: e20351. doi:10.1371/journal.pone.0020351 PONE-D-11-00027 [pii]
2. Weiss, J et al (2010) Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2: 62ra93. doi:10.1126/scitranslmed.3001451 2/62/62ra93 [pii]
3. Goke, F et al (2013) Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck. Mod Pathol. doi:10.1038/modpathol.2013.58modpathol201358 [pii]
4. Schrock A et al (2013) Fibroblast-growth-factor-receptor-1 as a potential therapeutic target in sinonasal cancer? Head Neck. doi:10.1002/hed.23443
5. Brunello, E et al (2012) FGFR-1 amplification in metastatic lymphnodal and haematogenous lobular breast carcinoma. J Exp Clin Cancer Res 31:103. doi:10.1186/1756-9966-31-103 1756-9966-31-103 [pii]
6. Lehnen NC et al (2013) Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma. Histopathology. doi:10.1111/his.12115
7. Gorringe KL et al (2007) High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clin Cancer Res 13:4731-4739. doi:10.1158/1078-0432.CCR-07-0502 (Pubitemid 47294779)
8. Simon R et al (2001) High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 61:4514-4519 (Pubitemid 32685782)
9. Goke F, Goke A, vonMassenhausen A, Franzen A, Sharma R, Kirsten R, Bohm D, Kristiansen G, Stenzinger A, Wynes M, Hirsch FR, WeichertW, Heasley L, Buettner R, Perner S (2013) Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer. Digestion 88:172-181. doi:10.1159/000355018 000355018 [pii]
10. Missiaglia E et al (2009) Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development. Gene Chromosome Cancer 48:455-467. doi:10.1002/gcc.20655
11. Braun, M et al (2012) Improved method of detecting the ERG gene rearrangement in prostate cancer using combined dualcolor chromogenic and silver in situ hybridization. J Mol Diagn 14:322-327. doi:10.1016/j.jmoldx.2012.01.017 S1525-1578(12)00100-6 [pii]
12. Perner S et al (2009) TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 217:65-72. doi:10.1002/path.2443
13. Goke, F et al (2012) Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors. Chest 142:1020-1026. doi:chest.11-2943 [pii] 10.1378/chest.11-2943
14. Zhao J et al (2002) Determination of HER2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod Pathol 15:657-665. doi:10.1038/modpathol.3880582 (Pubitemid 34666470)